One of our nurse educators mentioned that many nurses move the due time on the MAR for medications. We went live with Epic at the end of 2018 and this was noted as a recent practice. (We could not do this in Meditech before.)

Example: due time is 9 am but the nurse moves it to 8 am. Nurses can give a med 1 hr before or 1 hr after the due time.
In the example above, they move the due time to 8 am so that they can give and scan a med at 7:30 am.

They would like to bundle the meds and give them when they assess the patient rather than coming back at 9 am again.

Our institution implemented Code Malignant Hyperthermia (MH) last year.
COde Malignant Hyperthermia was mouthful for the caller and suggest we change the code name.
Any institution with Code MH, how is it called at your institution? Any recommendation?

The ASHP Medication Safety Section Advisory Group will be kicking off the 2020-21 year this month and are looking for ideas around new projects or subjects for work groups. This group is comprised of pharmacy leaders who serve in different roles in varying organizations, but share a passion for medication safety.

We are looking for a national benchmark for insulin harms on the inpatient population. Looking at severe hypoglycemia after administration of any insulin is a great metric put forward from the HIIN collaborative. However, with the quick changing patient mix toward the beginning of the year we quickly changed to harms/100,000 discharges which actually was a bit stable and conforms quite well to a control chart.

Either way, finding a benchmark of any type of metric would be desirable so we can continue to look at goal-setting.

For patients with scheduled PET scan, we generally avoid Dextrose containing meds, including any IV with D5W as the diluent 12 hours prior.

This is a challenge in the inpatient setting.

I'm wondering what system/workflow you have at your institution to ensure that patients scheduled for PET scan would not receive any D5W.

Is pharmacy or nursing involved in screening for patients scheduled for PET scan? and screening/switching IV drug diluents?

Thank you so much!

Does anyone have benchmarking goals for ADC Overrides in different patient care areas? Our organization consistently has total overrides for the organization < 0.75% (excluding ED). Our parent organization expects to see < 2% for the facility (excluding ED), but we don't have any expectation on the unit level.

Hello all,

Hello

I have had a question about the vitamin K IV drug monograph as the drug is listed as the generic name phytonadione. During an urgent situation the nurses were unable to find the monograph as Vitamin K as it was listed as the generic name. Wondering if anyone has encountered this issue? From another perspective the pharmacist responsible is hesitant to do anything with this as it may open "a can or worms" for other vitamins (Vitamin B, D). Any tips or suggestions.

Hi All,

Any suggestions on how to differentiate EPINEPHrine, Phenylephrine, and EPHEDrine vials in the OR?

We try to use pre-made, ready-to-use syringes from a 503b when possible, but due to supply issues, anesthesia still would like to have these items supplied as VIALS in the OR "just in case." We have Anesthesia PYXIS machines and try to leverage mini-drawers when possible, but some of our larger facilities that do more complex surgeries need those mini-drawers for controlled substance medications.

Would welcome all input!

-Jennifer

Hello,